The new national cholesterol guidelines
June 2001
The new national cholesterol guidelines recommend more intensive treatment...nearly TRIPLING the number of patients who are candidates for cholesterol-lowering drugs.
The guidelines now recommend the SAME treatment for patients at high risk for coronary heart disease (CHD) as they do for patients who already have CHD.
Patients with diabetes are automatically at high risk of CHD. So are many patients with two or more risk factors...hypertension...smoking...low HDL...or a family history of CHD.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote